Original document(6 pages)  中文版
    The slow released tolterodine tartate microcapsule preparation with homogeneous medicine release is one kind of slow release capsule with slow released microcapsule as main component, and the slow released microcapsule contains tolterodine tartate as the active component, slow releasing material and medicinal supplementary material in the weight ratio of 1-5 to 1-30 to 100-380. The preparation process of the slow released microcapsule includes the steps of mixing the main medicine component and the supplementary material, preparing the mixture into soft material, extruding and rounding. The slow released preparation can prolong the in vivo residence time of medicine, control the release of medicine, reduce medicine -taking times, lower the toxic side effect and raise curative effect.
Application Number
申请号
200510037144 Application Date
申请日
2005.09.13
Title 名称 Slow released tolterodine tartrate microcapsule and its prepn process
Publication Number
公开号
1931154 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/137;A61K9/52;A61P13/10
Applicant(s) Name
申请人
Zhuhai Tianyi Medicine Techn Development Co., Ltd., Zhuhai
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Fuel oil additive
Substituted isoquinolinones
Slow released indapamide microcapsule and its prepn process
New triterpene saponin componds with anticancer activity
PVDC composite film for seven-layer coextrusion processing and its method
Preparation method of minipills of 'Xiao Chai Hu'
Colon positioned releasing micropills and production thereof
Zinc, manganese silicate gree luminous fluorescent powder and its preparing method
Substituted 2h-1,3-benzoxazin-4(3h)-ones
Magnesium ion-regulating new expression vector
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.